Here’s Why VEON Shares Are Up Over 11% Today

Converged connectivity and online services provider VEON Ltd (NASDAQ:VEON) conducted a competitive sales process concerning its Russian operations. VEON’s management weighed…
  • Converged connectivity and online services provider VEON Ltd (NASDAQ:VEON) conducted a competitive sales process concerning its Russian operations.
  • VEON’s management weighed options to ensure an optimal outcome for all relevant stakeholders, including VEON, its Russian operations, its shareholders, its creditors, its customers, and employees working both in and outside Russia.
  • VEON reported second-quarter FY22 revenue growth of 5.6% year-on-year to $2.01 billion.
  • Total service revenue grew 7.1% Y/Y to $1.89 billion.
  • Mobile data revenue rose 11.6% Y/Y.
  • The 4G subscribers increased 19.2% Y/Y to 101.9 million.
  • Price Action: VEON shares traded higher by 11.10% at $0.39 on the last check Wednesday.
Total
0
Shares
Related Posts
Read More

First-Ever Clinical Trial On Magic Mushroom Therapy For Autism’s Genetic Cause Receives Approval

The partnership leading the way on psilocybin therapy for Fragile X Syndrome (FXS), the major genetic cause of Autism Spectrum Disorder (ASD), has received approval from Health Canada in the form of a No Objection letter and is set to proceed with the first-ever Phase 2a clinical trial on the magic mushrooms therapy for this condition.

KONEF